BTBD9 rs9296249: What Your Genotype Means
The rs9296249 variant is a specific change in the DNA sequence within the BTBD9 gene. It has been identified through genome-wide association studies as being linked to an increased susceptibility to restless legs syndrome (RLS), a condition characterized by an irresistible urge to move the legs, especially at night.
What each genotype means
Lower restless legs risk
This genotype is associated with a lower statistical risk of developing restless legs syndrome compared to those carrying the T allele. Because restless legs syndrome is a complex condition influenced by many genetic and environmental factors, this result does not guarantee the absence of the condition.
This is a common genotype found in many global populations, though exact frequencies vary by ancestry.
Increased restless legs risk
Carrying one copy of the T allele is associated with an increased statistical susceptibility to restless legs syndrome. Research indicates that variants in the BTBD9 gene contribute to the risk of this condition, though the effect size is moderate and influenced by other genetic and non-genetic factors.
This heterozygous genotype is common and observed frequently across diverse ancestral groups.
Higher restless legs risk
Carrying two copies of the T allele is associated with a higher statistical susceptibility to restless legs syndrome compared to individuals with the CC or CT genotypes. While this variant is a known risk factor, it is not a diagnostic marker; please consult with a healthcare provider if you experience symptoms such as uncomfortable sensations in the legs or an urge to move them.
This genotype is common in many populations, representing a significant portion of the genetic risk profile for restless legs syndrome in studied cohorts.
Understanding the rs9296249 Variant
The rs9296249 variant is a single nucleotide polymorphism (SNP) located within the BTBD9 gene on chromosome 6. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. While most of our DNA is identical, these small variations can influence how our bodies function or our susceptibility to certain health conditions. The rs9296249 variant is one of several markers within the BTBD9 region that researchers have studied to better understand the genetic architecture of sleep-related disorders. It is important to note that this variant is not a direct cause of a disease but rather a statistical marker that appears more frequently in individuals who have been diagnosed with restless legs syndrome compared to those who have not.
The Role of the BTBD9 Gene
The BTBD9 gene provides instructions for making a protein that contains a BTB/POZ domain, a structure known to facilitate protein-protein interactions. While the exact biological function of the BTBD9 protein remains a subject of ongoing scientific investigation, research using model organisms like fruit flies and mice suggests it may play a role in neurological processes. Studies have shown that when the homolog of this gene is disrupted in animal models, the subjects can display behaviors that resemble features of restless legs syndrome. Because the protein is expressed in areas of the brain such as the hippocampus, scientists hypothesize that it may be involved in pathways that regulate sleep, movement, or sensory processing. However, much of this research is still in the experimental phase, and the precise mechanism by which BTBD9 influences human sleep remains to be fully elucidated.
Evidence and Research Associations
The association between rs9296249 and restless legs syndrome was first highlighted in large-scale genome-wide association studies (GWAS). These studies compare the genomes of thousands of people to find patterns that correlate with specific traits or conditions. Multiple independent research groups have replicated the finding that this variant is associated with an increased risk of developing RLS. While the statistical evidence is significant, the effect size of any single variant like rs9296249 is generally modest. Restless legs syndrome is considered a complex, polygenic condition, meaning it is likely influenced by the combined effects of many different genetic variants, as well as environmental and lifestyle factors. Consequently, possessing this variant does not guarantee that an individual will develop the condition, and many people without the variant may still experience RLS.
Population Frequency
The rs9296249 variant is considered common across various human populations. Research has confirmed its association with restless legs syndrome in diverse groups, including Caucasian and Korean populations, suggesting that the role of the BTBD9 gene in RLS susceptibility may be relatively universal. Because the variant is common, a significant portion of the general population carries at least one copy of the risk-associated allele. This high frequency underscores the fact that genetic predisposition is only one piece of the puzzle. Most people who carry common risk variants do not develop the associated condition, which highlights the importance of other factors, such as iron levels, overall health, and environmental triggers, in the manifestation of restless legs syndrome.
What This Information Means for You
Learning about your genetic variants can be an interesting way to explore your biological makeup, but it is essential to interpret this information with caution. The presence of the rs9296249 variant is a statistical association, not a medical diagnosis. It cannot predict whether you will develop restless legs syndrome, nor can it explain the severity of symptoms if you already have the condition. If you are experiencing symptoms such as uncomfortable sensations in your legs or difficulty sleeping, it is important to consult with a healthcare professional. They can provide a proper clinical evaluation, which may include checking your iron levels or reviewing your sleep history. Never use genetic information to make decisions about your health or to self-diagnose. Always discuss any concerns about sleep quality or potential treatments with your doctor or a qualified sleep specialist.
How common is this variant?
The rs9296249 variant is common across global populations, with the risk-associated alleles appearing frequently in both European and Asian ancestral groups.
Frequently asked questions
Does having the rs9296249 variant mean I have restless legs syndrome?
No. This variant is only a statistical marker associated with an increased risk of the condition. Many people with this variant never develop restless legs syndrome, and it is not a diagnostic tool.
Can I use this genetic information to prevent RLS?
There is no known way to use this specific genetic information to prevent restless legs syndrome. RLS is a complex condition influenced by many factors, and you should focus on overall sleep hygiene and consulting a doctor for any symptoms.
Is BTBD9 the only gene linked to restless legs syndrome?
No, restless legs syndrome is a polygenic condition. Research has identified several other genes, such as MEIS1, PTPRD, and MAP2K5, that are also associated with susceptibility to the disorder.
Should I get tested for this SNP?
Genetic testing for this specific SNP is not recommended for clinical purposes. Because the association is modest and does not provide a diagnosis, it does not change how a doctor would evaluate or treat your symptoms.
Sources & further reading
Educational information only, last refreshed 10/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs9296249?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in BTBD9
The minor allele of this SNP is associated with a reduced risk of developing restless legs syndrome.
Intronic variant strongly associated with restless legs syndrome (RLS) susceptibility and periodic limb movements during sleep (PLMS), mediating altered iron homeostasis.
A prominent non-coding variant in BTBD9 strongly conferring risk for periodic limb movements during sleep and restless legs syndrome.
Genome-wide significant intronic susceptibility variant in BTBD9 strongly predisposing individuals to restless legs syndrome and periodic limb movements in sleep.
A regulatory intron variant in BTBD9 strongly associated with periodic limb movements in sleep and fragmented sleep architecture.
Well-validated intronic risk variant in BTBD9 strongly associated with periodic limb movement in sleep (PLMS) and restless legs syndrome (RLS).